| Inventor | Institute |
|---|---|
| Nathan E. Reticker-Flynn | Stanford University |
| SKU: | 162232 |
|---|---|
| Product description: | Seventh generation cell line derived from an ipsilateral brachial lymph node metastasis of a sixth-generation line |
| Gender: | Female |
| CRISPR: | No |
| Production details: | Line was isolated from a brachial lymph node metastasis after roughly one month of growth of a LN6 tumor |
| Parental cell line: | B16-F0 |
| Model description: | A luciferase transgene was integrated into the B16-F0 parental line, but is no longer expressed in LN metastatic progeny. WES suggests the presence of Braf and Pten mutations. |
| Disease: | Melanoma |
| Cat. #: | 162232 |
|---|---|
| Cancer types: | Skin cancer |
| Organism: | Mouse |
| Tissue: | Skin (lymph node metastasis) |
| Gender: | Female |
| Model: | Tumorigenic cell line; syngeneic |
| Morphology: | Mixed morphology that is predominantly spindle-shaped |
| Storage conditions: | Liquid Nitrogen |
|---|---|
| Shipping conditions: | Dry Ice |
| Growth medium: | DMEM (high glucose) + 10% FBS + 4mM L-glutamine (or GlutaMAX) + 1% Pen/Strep (optional) |
| Subculture routine: | See product datasheet |
| Temperature: | 37C |
| Atmosphere: | 5% CO₂ |
| Storage medium: | DMEM, 50% FBS, 10% DMSO |
| Mycoplasma free: | Yes |
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.